3rd Edition of Dementia World Conference 2026

Scientific Sessions

Neuropharmacology

Advances in Neuropharmacology for Dementia Treatment

Neuropharmacology examines how drugs and other substances impact the brain and nervous system, focusing mainly on dementia. It develops medications that might ease symptoms, slow the disease's progress, or improve cognitive functions. Global scientists are joining the Alzheimer’s Research Summit to share breakthroughs in Alzheimer’s therapies and care. Advances in neuropharmacology are essential for treating dementia and may provide new treatment options. The Dementia World Conference (DWC) will highlight recent developments in neuropharmacology and discuss how these findings could support individuals with dementia.

Related Sessions

Dementia
Brain Aging
Alzheimers Disease
Vascular Dementia
Mixed Dementia
Multiple sclerosis and Dementia
Parkinson Disease
Neurodegenerative Diseases
Stages of Dementia
Neuropharmacology
Neuroepigenetics
Geriatrics Dementia
Cognitive Disorder
Causes and Prevention of Dementia
Dementia Care, Practice, and Awareness
 Clinical Neurology
Neurosurgeries
Depression Symptoms
Immunotherapy
Genetics in Dementia
Memory Disorders
Cognitive Impairment
Aphasia
Speech Disorders
Cognitive-Communication Disorders
Semantic Dementia
Posterior Cortical Atrophy
Posterior Cortical Atrophy
Corticobasal Syndrome
REM Sleep Behavior Disorder
NMDA Receptor Antibody Encephalitis
NMDA Receptor Antibody Encephalitis
Creutzfeldt-Jakob Disease
Chronic Traumatic Encephalopathy
Wernicke-Korsakoff Syndrome
Huntington’s Disease
Behavioral Neurology
Dysphagia Care